Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Study of NNZ-2566 in Patients With Traumatic Brain Injury (TBI) Conducted Under an Exception From Informed Consent (EFIC)
NCT01366820 is registered in ClinicalTrials.gov with Neuren Pharmaceuticals Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Study of NNZ-2566 in Patients With Traumatic Brain Injury (TBI) Conducted Under an Exception From Informed Consent (EFIC)
- Lead sponsor
- Neuren Pharmaceuticals Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- January 31, 2016
- Enrollment
- 261 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.